UBS Global Life Sciences Conference to Webcast OrthoLogic Presentation
September 19 2005 - 2:15PM
PR Newswire (US)
TEMPE, Ariz., Sept. 19 /PRNewswire-FirstCall/ -- OrthoLogic, Inc.
(NASDAQ:OLGC) announced today that its presentation at the UBS
Global Life Sciences Conference will be webcast live and may be
accessed by visiting the Investors section of the Company's
website, http://www.orthologic.com/. OrthoLogic management will
provide an overview of the Company and an update on its lead
compound for tissue and bone healing, Chrysalin(R). The
presentation will be delivered at 10:00 a.m. EDT on Monday,
September 26, 2005 from The Grand Hyatt Hotel in New York City. The
presentation will be archived for 30 days. OrthoLogic is a
biotechnology company focused on the development and
commercialization of the novel synthetic peptide Chrysalin(R)
(TP508) in three lead indications, all of which represent areas of
significant unmet medical need -- fracture repair, diabetic foot
ulcer healing and cartilage defect repair. Based on the Company's
pioneering scientific research of the natural healing cascade,
OrthoLogic has become the leading company focused on tissue and
bone repair. OrthoLogic is committed to developing a pipeline of
novel peptides and other molecules aimed at helping patients with
equally under-served conditions. The Company maintains exclusive
worldwide rights for Chrysalin. OrthoLogic's corporate headquarters
are in Tempe, Arizona. For more information, please visit the
company's Web site: http://www.orthologic.com/. Editors' Note: This
press release is also available under the Investor section of the
Company's website at: http://www.orthologic.com/. DATASOURCE:
OrthoLogic, Inc. CONTACT: Media: Lauren Tortorete of Biosector 2,
+1-212-845-5609; or Investors: Melanie Friedman of Stern Investor
Relations, +1-212-362-1200 Web site: http://www.orthologic.com/
Copyright
Orthologic (MM) (NASDAQ:OLGC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Orthologic (MM) (NASDAQ:OLGC)
Historical Stock Chart
From Aug 2023 to Aug 2024